FDA Inspection 1053612 — Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site)
The FDA completed an inspection of Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) on May 14, 2018 in Lianyungang. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 14, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lianyungang (China)